Valor Resources Limited (ASX:VAL) is an exploration company focussed on creating shareholder value through acquisitions and exploration activities. The Company is focussed on two key projects as outlined below in Peru and Canada. Valor’s 100% owned Peruvian subsidiary, Kiwanda SAC holds the rights to the Picha & Berenguela South Projects located in the Moquegua Department…
U.S. Energy Corp. plans public offering of common stock
HOUSTON: U.S. Energy Corp. has announced intention to offer its common shares in an underwritten public offering. In connection with the offering, the Company expects to grant the underwriters a 45-day option to purchase an additional 15% of the shares of its common stock offered in the public offering on the same terms and conditions….
Wattle Health acquires remaining 20% of Little Innoscents
SYDNEY: Wattle Health Australia Limited has entered into a Share Sale Agreement (SSA) to acquire the remaining 20% of Little Innoscents (LI) for $200,000, taking the Company’s ownership of LI to 100%. Little Innoscents has established a reputation as a premium brand in the natural and organic skincare sector and has produced growing month-on-month sales,…
urban-gro announces pricing of $54mn public offering and Nasdaq listing
LAFAYETTE: urban-gro Inc. announced the pricing of an underwritten public offering of 5.4 million shares at a public offering price of $10 per share for aggregate gross proceeds of $54 million. In addition, urban-gro has granted the underwriters a 45-day option to purchase up to an additional 810,000 shares of common stock at the public…
Starpharma signs research agreement with MSD
MELBOURNE: Starpharma Holdings has signed a Research Agreement with MSD, the tradename of Merck & Co., Inc., Kenilworth NJ USA. Under the agreement, MSD will conduct a preclinical research evaluation of dendrimer based Antibody Drug Conjugates (ADCs) utilising Starpharma’s proprietary DEP technology. Dr Jackie Fairley, CEO of Starpharma commented: “MSD is a recognised leader in…
Starpharma Holdings Limited (ASX:SPL)
Click Here Starpharma Holdings Limited (ASX:SPL) share price Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) is a global biopharmaceutical company and a world leader in the development of new pharmaceutical and medical products based on proprietary polymers called dendrimers, with programs for COVID-19, DEP® drug delivery and VivaGel®. Starpharma is developing VIRALEZE™, an antiviral nasal spray for…
Oncorus prices public offering of 3.0 million common shares
CAMBRIDGE: Oncorus Inc. announced the pricing of its underwritten public offering of 3.0 million shares of its common stock at a price to the public of $19 per share. All shares of common stock in the offering are being offered by Oncorus. The gross proceeds to Oncorus from the offering, before deducting underwriting discounts and…
Baring Private Equity Asia completes acquisition of Virtusa
SOUTHBOROUGH: Baring Private Equity Asia (BPEA) has completed the acquisition and privatization of Virtusa Corporation, a global provider of digital strategy, digital engineering, and IT services and solutions that help clients change and disrupt markets through innovation engineering. In conjunction with the closing, Virtusa’s common stock will cease trading before the market opens on February…
WEX signs agreement to acquire HSA assets of HealthcareBank
PORTLAND: WEX Inc., a financial technology service provider, announced the signing of an agreement to acquire certain health savings account (HSA) assets of HealthcareBank, the custodian bank for customers of WEX’s Health division. Pursuant to the terms of the agreement, WEX will pay an initial cash consideration of approximately $200 million, with two additional deferred…
U.S. buys additional 100 million doses of Moderna’s COVID-19 vaccine
CAMBRIDGE: Moderna Inc. announced that the U.S. government has purchased an additional 100 million doses of Moderna’s COVID-19 Vaccine, bringing its confirmed order commitment to 300 million doses. Moderna has supplied 41 million released doses of the vaccine to the U.S. government to date. More than 22 million Americans have received the Moderna COVID-19 Vaccine…
Madison Realty Capital originated more than $1.5 Billion in transactions during 2020
NEW YORK: Madison Realty Capital (MRC) completed more than $1.5 billion in financing, originations and performing and non-performing note purchases in 2020, ranging from $4.9 million to $173 million, a news release said. The firm closed a total of 23 transactions in major U.S. metropolitan and suburban markets across a variety of real estate asset…
Shell accelerates drive for net-zero emissions with customer-first strategy
THE HAGUE: Shell has set out its strategy to accelerate its transformation into a provider of net-zero emissions energy products and services, powered by growth in its customer-facing businesses. A disciplined cash allocation framework and rigorous approach to driving down carbon emissions will deliver value for shareholders, customers and wider society. Shell also confirmed its…